Literature DB >> 34987973

A novel ablation strategy for refractory atrial fibrillation based on the fractionated signal area in the atrial muscle.

Jun Hirokami1, Kenichi Hiroshima1, Michio Nagashima1, Masato Fukunaga1, Kengo Korai1, Kenji Ando1.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Fractionated signal; Non–pulmonary vein foci; Radiofrequency ablation; Refractory atrial fibrillation

Year:  2021        PMID: 34987973      PMCID: PMC8695288          DOI: 10.1016/j.hrcr.2021.09.010

Source DB:  PubMed          Journal:  HeartRhythm Case Rep        ISSN: 2214-0271


× No keyword cloud information.

Introduction

Pulmonary vein isolation (PVI) for atrial fibrillation (AF) is a well-established treatment.1, 2, 3 Non–pulmonary vein (PV) trigger elimination can improve the recurrence rate after paroxysmal and persistent AF ablation., However, complete non-PV trigger elimination is challenging owing to difficulty in detecting the non-PV foci. We developed a novel visualization tool of the fractionated signal area in the atrial muscle (FAAM) map, which highlights the fractionated signal area using Lumipoint software in the ultra-high-density Rhythmia (Boston Scientific, Marlborough, MA) system and successfully identifies the non-PV foci. Herein, we report a novel ablation strategy, FAAM ablation, which is effective for refractory AF.

What the FAAM map is

FAAM maps were created using Lumipoint software in the Rhythmia system on an offline workstation. Low-voltage areas were defined as areas with amplitudes between 0.1 and 0.5 mV, and no-voltage areas were defined as areas with amplitudes of <0.03 mV. A fractionated signal was defined as a waveform with 2 or more fragmented deflections during sinus rhythm or atrial pacing. The FAAM was defined as the area where fractionated signals could be detected in the atrium. FAAM maps were assigned by a peaks slider, which is an original parameter of Lumipoint. The peaks slider indicates the number of components of fractionated signals and ranges from 1 to 15. If a large peaks slider was set, Lumipoint highlighted a small area that only had high fractionated signals; the larger the peaks slider is, the smaller the FAAM is. The “Activation search” function of the Lumipoint software was applied to all atrial maps. This feature uses an adjustable time-of-interest period within the mapping window to highlight all electrocardiograms (ECGs) that show activity during the time-of-interest period. The “Complex Activation search” function highlights ECGs that show activity within the time-of-interest period and exhibit multiple fractionated signals. The “Complex Activation search” of Lumipoint highlighted the FAAM in the antrum.

Case report

A 69-year-old man was diagnosed with symptomatic persistent AF 9 years ago. He had undergone PVI, superior vena cava (SVC) isolation, and ganglionated plexi ablation for persistent AF. Five years ago, he had recurrence of tachycardia by atrial tachycardia; thus he had undergone left atrial (LA) roof area ablation for atrial premature beat, and mitral isthmus and LA anterior line ablation for persistent atrial tachycardia. He had paroxysmal AF recurrence 1 year ago and frequent episodes of drug-resistant palpitation. He required a third catheter ablation session. Patients were permitted to this study participation upon admission to hospital. At admission, 12-lead ECG showed sinus rhythm. A transthoracic echocardiogram showed a normal left ventricular ejection fraction of 65.4%, LA diameter of 35.5 mm, and LA volume index of 21.2. Laboratory data were as follows: brain natriuretic peptide, 15.0 pg/mL; thyroid-stimulating hormone, 2.87 μIU/mL; free thyroxine, 1.18 ng/dL; blood urea nitrogen, 14.7 mg/dL; and creatinine, 0.90 mg/dL. His past medical history was only significant for dyslipidemia: CHADS2 score 0 and CHA2DS2-VASc score 1 for age 65–74 years (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, history of stroke or transient ischemic attack, vascular disease, age 65–74, and sex). He was administered dabigatran etexilate methanesulfonate, 220 mg/day; bepridil hydrochloride hydrate, 100 mg/day; pitavastatin calcium hydrate, 2 mg/day; and verapamil hydrochloride, 40 mg pill-in-the-pocket. During the procedure, a 20-pole catheter was inserted through the right jugular vein. The proximal electrodes were positioned along the SVC and crista terminalis, and the distal electrodes were placed in the coronary sinus. If AF continued, it was terminated using intracardiac defibrillation. After performance of the standard Brockenbrough technique, mapping was performed using the ultra-high-density Rhythmia system during sinus rhythm with an Orion mapping catheter (Boston Scientific, Marlborough, MA). The following beat acceptance criteria were used: cycle length, propagation reference by the coronary sinus catheter distal and proximal electrodes, respiratory stability, motion stability of the Orion mapping catheter within 1 mm, and maximal distance of 2 mm between the electrode and anatomical shell. In this procedure, all PVs and the SVC were isolated. The low-voltage line was in LA anterior from mitral to right superior PV. Scar zones were in the LA roof area (Figure 1). We analyzed non-PV triggers with electrode catheters by administering a bolus injection of adenosine triphosphate (ATP; 60 mg) during a continuous infusion of isoproterenol (ISP; 10 μg/kg/min). However, detection of all non-PV triggers was difficult because of multiple spontaneous ectopic beats and induction of incessant AF. We previously reported FAAM is related to non-PV foci. Therefore, we decided to ablate the FAAM.
Figure 1

Voltage map and fractionated signal areas in atrial muscle (FAAM) map. A, B: Voltage map of left atrium showed broad low-voltage area in anterior wall and posterior roof wall. Non–pulmonary vein foci that could be detected (yellow arrows) were located within FAAM of peaks slider 6.0. C, D: Voltage map of right atrium showed almost-normal voltage. Sinus node (white arrows) and atrioventricular node (red arrows) were located near or within FAAM of peaks slider 5.0.

Voltage map and fractionated signal areas in atrial muscle (FAAM) map. A, B: Voltage map of left atrium showed broad low-voltage area in anterior wall and posterior roof wall. Non–pulmonary vein foci that could be detected (yellow arrows) were located within FAAM of peaks slider 6.0. C, D: Voltage map of right atrium showed almost-normal voltage. Sinus node (white arrows) and atrioventricular node (red arrows) were located near or within FAAM of peaks slider 5.0. Non-PV triggers, which we successfully detected, were located within the LA FAAM of peaks slider 6.0. We initially ablated the LA FAAM of peaks slider 6.0 during AF, and AF returned to sinus rhythm (Figure 2A). We also ablated the right atrial FAAM of peaks slider 6.0 owing to remaining multiple atrial premature beats (Figure 3). We needed to carefully avoid the sinus node and atrioventricular (AV) node because these areas were highlighted as FAAMs. Non-PV triggers were completely eliminated by administering a bolus injection of ATP (60 mg, until sinus arrest) during continuous infusion of ISP (10 μg/kg/min); finally, AF was not induced. We induced sustained AF via rapid atrial pacing (50 ms/30 mA/5 s) at the high right atrium during ISP infusion, and AF spontaneously returned to sinus rhythm (Figure 2B). No sequelae were observed.
Figure 2

Atrial electrograms during ablation of fractionated signal areas in atrial muscle (FAAM) in left atrium. A: Atrial fibrillation (AF) was terminated by ablation on FAAM. B: After ablating of FAAM in bilateral atrium, we induced sustained AF via rapid atrial pacing (50 ms/30 mA/5 s) at the high right atrium during isoproterenol infusion, and AF spontaneously returned to sinus.

Figure 3

Fractionated signal areas in atrial muscle (FAAM) map and ablation points. FAAM of peaks slider 6.0 were highlighted in left atrium (A, B) and right atrium (C, D). Blue points show ablation points within the FAAM ablated. Non–pulmonary vein foci are indicated by yellow arrows. Sinus node (white arrows) and atrioventricular node (red arrows) were not located within FAAM of peaks slider 6.0.

Atrial electrograms during ablation of fractionated signal areas in atrial muscle (FAAM) in left atrium. A: Atrial fibrillation (AF) was terminated by ablation on FAAM. B: After ablating of FAAM in bilateral atrium, we induced sustained AF via rapid atrial pacing (50 ms/30 mA/5 s) at the high right atrium during isoproterenol infusion, and AF spontaneously returned to sinus. Fractionated signal areas in atrial muscle (FAAM) map and ablation points. FAAM of peaks slider 6.0 were highlighted in left atrium (A, B) and right atrium (C, D). Blue points show ablation points within the FAAM ablated. Non–pulmonary vein foci are indicated by yellow arrows. Sinus node (white arrows) and atrioventricular node (red arrows) were not located within FAAM of peaks slider 6.0. After the discharge, there was no AF recurrence after 1-, 3-, 6-, 12-, and 18-month ECG follow-up and 6- and 12-month 24-Holter ECG follow-up. The patient did not experience any palpitation.

Discussion

Bilateral PVI at the antrum is the preferred treatment strategy for AF., The complete elimination of the non-PV foci results in a significant improvement in terms of AF recurrence rates compared to those in patients in whom non-PV triggers were not completely eliminated., This report shows that FAAM ablation was effective in eliminating the non-PV foci in patients with refractory AF. Therefore, AF recurrence was potentially improved. The FAAM may play a prominent role in AF induction. Abnormal atrial electrograms recorded during sinus rhythm are related to atrial vulnerabilities such as repetitive atrial firing., When a single extrastimulus is applied to the atrium early in diastole, the local atrial electrogram will widen. Moreover, repetitive atrial firing and sustained AF tend to be induced by extrastimuli in patients with fractionated signal areas. We hypothesized that non-PV triggers that would occur within the FAAM are significantly implicated in the induction and perpetuation of AF. Our novel FAAM map, which can be used as a predictor of the non-PV foci, can help completely eliminate the non-PV foci and improve AF recurrence rates. Notably, both the sinus node and AV node areas present high-fractionated signals as FAAMs. Therefore, close attention is needed to avoid iatrogenic sick sinus syndrome and AV block. In this case, FAAM ablation was significantly effective for refractory AF. Non-PV triggers could not be identified by ISP and ATP infusion, and AF was terminated during FAAM ablation. FAAM ablation succeeded in elimination of non-PV triggers. We also performed FAAM ablation in 5 other patients with refractory AF; non-PV triggers were completely ablated successfully (Table 1). They did not experience AF recurrence on regular ECG and 24-Holter ECG follow-up over 1 year.
Table 1

Characteristics of other 5 patients who underwent ablation of fractionated signal areas in atrial muscle

AgeType of rhythm in admissionPrevious procedureNon-PV triggersPeaks slider of ablating areaComplicationOutcome
68AF4 PVI + roof line + LA posterior areaIncessant AF from RA posterior FAAM and multiple APCs from LALA 6.0 area and RA 6.0 areaNoneGood. No AT/AF recurrence
63Sinus4 PVI + CTIMultiple APCs from bilateral antrumLA 6.0 area and RA 7.0 areaNoneGood. No AT/AF recurrence
66AF4 PVI + box isolation + Marshall ablation + posterior mitral isthmus lineIncessant AF from LA bottom FAAM and multiple APCs from RALA 5.0 area and RA 5.0 areaNoneGood. No AT/AF recurrence by pacemaker remote monitoring
79AF4 PVI + CTIMultiple APCs from bilateral antrumLA 7.0 area and RA 6.5 areaNoneGood. No AT/AF recurrence
47Sinus4 PVI + LA/RA septal area + LA posterior areaIncessant AF from RA posterior FAAMLA 6.0 area and RA 5.0 areaNoneGood. No AT/AF recurrence

AF = atrial fibrillation; APC = atrial premature contraction; AT = atrial tachycardia; CTI = cavotricuspid isthmus line; FAAM = fractionated signal areas in atrial muscle; LA = left atrial; PV = pulmonary vein; PVI = pulmonary vein isolation; RA = right atrial.

Characteristics of other 5 patients who underwent ablation of fractionated signal areas in atrial muscle AF = atrial fibrillation; APC = atrial premature contraction; AT = atrial tachycardia; CTI = cavotricuspid isthmus line; FAAM = fractionated signal areas in atrial muscle; LA = left atrial; PV = pulmonary vein; PVI = pulmonary vein isolation; RA = right atrial.

Limitations

Although this report is limited by its single-center setting and a small sample size, to the best of our knowledge, this is the first-in-man feasibility study of FAAM ablation. Further investigation is required to validate our findings and to prospectively evaluate the long-term effectiveness of FAAM ablation.

Conclusion

Our proof-of-concept study demonstrated that the novel FAAM ablation technique successfully eliminates non-PV triggers and improves refractory AF. Larger confirmatory studies are needed to validate that FAAM ablation improves the AF recurrence rate in patients with refractory AF. Fractionated signal area in the atrial muscle (FAAM) is a valid predictor of the non–pulmonary vein foci in patients with atrial fibrillation (AF). Careful attention is needed during FAAM ablation because the sinus node and atrioventricular node also show high FAAM. FAAM ablation could improve the recurrence rate of AF in patients with refractory AF. A larger confirmatory study is needed.
  7 in total

1.  Relationship Between Fractionated Signal Areas in the Atrial Muscle During Sinus Rhythm and Atrial Pacing and Non-pulmonary Vein Foci: A Novel Mapping Strategy.

Authors:  Jun Hirokami; Kenichi Hiroshima; Kyohei Yamaji; Kengo Korai; Michio Nagashima; Masato Fukunaga; Junji Morita; Kei Yamamoto; Kenji Ando; Masahiko Goya
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-06

2.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

3.  Approaches to catheter ablation for persistent atrial fibrillation.

Authors:  Atul Verma; Chen-yang Jiang; Timothy R Betts; Jian Chen; Isabel Deisenhofer; Roberto Mantovan; Laurent Macle; Carlos A Morillo; Wilhelm Haverkamp; Rukshen Weerasooriya; Jean-Paul Albenque; Stefano Nardi; Endrj Menardi; Paul Novak; Prashanthan Sanders
Journal:  N Engl J Med       Date:  2015-05-07       Impact factor: 91.245

4.  Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation.

Authors:  Kentaro Hayashi; Yoshimori An; Michio Nagashima; Kenichi Hiroshima; Masatsugu Ohe; Yu Makihara; Kennosuke Yamashita; Schoichiro Yamazato; Masato Fukunaga; Koichiro Sonoda; Kenji Ando; Masahiko Goya
Journal:  Heart Rhythm       Date:  2015-05-08       Impact factor: 6.343

5.  Clinical impact of eliminating nonpulmonary vein triggers of atrial fibrillation and nonpulmonary vein premature atrial contractions at initial ablation for persistent atrial fibrillation.

Authors:  Shota Tohoku; Masato Fukunaga; Michio Nagashima; Kengo Korai; Jun Hirokami; Kei Yamamoto; Ayaka Takeo; Harushi Niu; Kenji Ando; Kenichi Hiroshima
Journal:  J Cardiovasc Electrophysiol       Date:  2020-12-18

6.  Repetitive atrial firing and fragmented atrial activity elicited by extrastimuli in the sick sinus syndrome with and without abnormal atrial electrograms.

Authors:  O A Centurion; A Shimizu; S Isomoto; A Konoe; T Hirata; O Hano; M Kaibara; K Yano
Journal:  Am J Med Sci       Date:  1994-04       Impact factor: 2.378

7.  Relation between the widening of the fragmented atrial activity zone and atrial fibrillation.

Authors:  T Ohe; M Matsuhisa; S Kamakura; J Yamada; I Sato; K Nakajima; K Shimomura
Journal:  Am J Cardiol       Date:  1983-12-01       Impact factor: 2.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.